deamino-arginine-vasopressin and Hepatitis-B

Topics: Deamino Arginine Vasopressin; Factor IX; Factor VIII; Female; Genetic Carrier Screening; Hemophilia A; Hemorrhage; Hepatitis B; HIV Infections; Humans; Infant, Newborn; Pregnancy; Prenatal Diagnosis; Recombinant Proteins

Treatment of hemophilia and von Willebrand's disease has become easier in recent years because of the development of more effective factor replacement products. The median age and the life expectancy of patients with hemophilia have risen markedly, as has the median age at death.

Topics: Acquired Immunodeficiency Syndrome; Antigens; Blood Coagulation Factors; Cerebral Hemorrhage; Danazol; Deamino Arginine Vasopressin; Factor VIII; Female; Gastrointestinal Hemorrhage; Hemophilia A; Hemorrhage; Hepatitis B; Hepatitis C; Humans; Pregnancy; Surgical Procedures, Operative; Thrombosis; Tooth Extraction; von Willebrand Diseases

Topics: Acquired Immunodeficiency Syndrome; Antigens; Blood Coagulation Tests; Blood Transfusion; Child; Deamino Arginine Vasopressin; Factor IX; Factor VIII; Female; Genetic Carrier Screening; Hemophilia A; Hepatitis B; Humans; Pregnancy; Prenatal Diagnosis; von Willebrand Diseases; von Willebrand Factor